Back4d Pharma Plc - Warrants (22/02/2025) Overview

4d Pharma Plc - Warrants (22/02/2025) Current Cash

Latest current cash for LBPSW: $21M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$20.97M
139.01% YoYΔ $12.20M vs prior year quarter

Peer average

Loading

4d Pharma Plc - Warrants (22/02/2025) Current Cash History

Loading

4d Pharma Plc - Warrants (22/02/2025) vs. peers: Current Cash Comparison

Loading

4d Pharma Plc - Warrants (22/02/2025) Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

4d Pharma Plc - Warrants (22/02/2025) (LBPSW) FAQ

The latest current cash for LBPSW is $21M as of December 2021. That compares with $8.8M in the prior-year period — up 139.0% year over year. Investors often review this figure alongside 4d Pharma Plc - Warrants (22/02/2025)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, LBPSW's current cash moved from $8.8M to $21M — a 139.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in 4d Pharma Plc - Warrants (22/02/2025)'s operating scale or balance-sheet position.

A current cash figure of $21M for LBPSW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting LBPSW's current cash ($21M), review year-over-year change from $8.8M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack 4d Pharma Plc - Warrants (22/02/2025)'s current cash against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.